Experimental Factor Ontology (EFO) Information | |
Identifier | EFO_0000464 |
Description | A subcategory of chronic obstructive pulmonary disease (COPD). It occurs in people who smoke and suffer from chronic bronchitis. It is characterized by inflation of the alveoli, alveolar wall damage, and reduction in the number of alveoli, resulting in difficulty breathing. [NCIT: C3348] | Trait category |
Other disease
|
Synonyms |
5 synonyms
|
Mapped terms |
16 mapped terms
|
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS001326 (GBE_HC431) |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Emphysema | emphysema | 42 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS001326/ScoringFiles/PGS001326.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM009117 | PGS001326 (GBE_HC431) |
PSS004496| African Ancestry| 6,497 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Emphysema | — | AUROC: 0.79508 [0.66687, 0.92329] | R²: 0.11615 Incremental AUROC (full-covars): -0.00299 PGS R2 (no covariates): 6e-05 PGS AUROC (no covariates): 0.54363 [0.35853, 0.72873] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009118 | PGS001326 (GBE_HC431) |
PSS004497| East Asian Ancestry| 1,704 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Emphysema | — | AUROC: 0.98854 [0.98287, 0.99422] | R²: 0.35967 Incremental AUROC (full-covars): 0.00059 PGS R2 (no covariates): 0.01376 PGS AUROC (no covariates): 0.67098 [0.43987, 0.90208] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009119 | PGS001326 (GBE_HC431) |
PSS004498| European Ancestry| 24,905 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Emphysema | — | AUROC: 0.7867 [0.75313, 0.82026] | R²: 0.09488 Incremental AUROC (full-covars): -0.00065 PGS R2 (no covariates): 0.0 PGS AUROC (no covariates): 0.49994 [0.45601, 0.54388] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009120 | PGS001326 (GBE_HC431) |
PSS004499| South Asian Ancestry| 7,831 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Emphysema | — | AUROC: 0.78275 [0.67463, 0.89087] | R²: 0.0813 Incremental AUROC (full-covars): 0.00398 PGS R2 (no covariates): 0.00648 PGS AUROC (no covariates): 0.59809 [0.42688, 0.7693] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PPM009121 | PGS001326 (GBE_HC431) |
PSS004500| European Ancestry| 67,425 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: Emphysema | — | AUROC: 0.72797 [0.70437, 0.75156] | R²: 0.05838 Incremental AUROC (full-covars): 0.00547 PGS R2 (no covariates): 0.00531 PGS AUROC (no covariates): 0.56911 [0.54137, 0.59684] |
age, sex, UKB array type, Genotype PCs | Full Model & PGS R2 is estimated using Nagelkerke's method |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS004496 | — | — | [
|
— | African unspecified | — | UKB | — |
PSS004497 | — | — | [
|
— | East Asian | — | UKB | — |
PSS004498 | — | — | [
|
— | European | non-white British ancestry | UKB | — |
PSS004499 | — | — | [
|
— | South Asian | — | UKB | — |
PSS004500 | — | — | [
|
— | European | white British ancestry | UKB | Testing cohort (heldout set) |